AQUA CORNCT07932314
Prognostic Value of Oxygen-15 Water PET in Coronary Artery Disease
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Eligibility criteria changed
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Prognostic Thresholds of Stress Myocardial Blood Flow for Predicting MACE-1 (Main Basket)
Timeframe: 2 and 5 years after the PET examination
Prognostic Thresholds of Rest Myocardial Blood Flow for Predicting MACE-1 (Main Basket)
Timeframe: 2 and 5 years after the PET examination
Prognostic Thresholds of Myocardial Flow Reserve for Predicting MACE-1 (Main Basket)
Timeframe: 2 and 5 years after the PET examination
Secondary (4)
Subgroup-Specific Prognostic Thresholds of Myocardial Blood Flow and Myocardial Flow Reserve for Predicting MACE-1 (Main Basket)
Prognostic Thresholds of Myocardial Blood Flow and Myocardial Flow Reserve for Predicting MACE-2 (Main Basket)
Subgroup-Specific Prognostic Thresholds of Myocardial Blood Flow and Myocardial Flow Reserve for Predicting MACE-2 (Main Basket)
Prognostic Thresholds of Myocardial Blood Flow and Myocardial Flow Reserve for Predicting Individual Cardiovascular and Non-Cardiovascular Events (Main Basket)
Arms and interventions
Oxygen-15 Water PETExperimental
In the main basket, participants will undergo a single quantitative myocardial perfusion imaging examination using oxygen-15 water PET at rest and during pharmacological stress (adenosine or regadenoson). In the additional baskets, the same examination will be performed twice, at baseline and at follow-up. In all baskets, blood samples will be collected when feasible and stored in a biobank for future research.
Drugs: Oxygen-15 Water
Sites
1 site in 1 country
- Department of Clinical Physiology, Sahlgrenska University HospitalGothenburg, Sweden